Back to Browse Journals

Pragmatic and Observational Research


Professor Price

Observational and Pragmatic Research Institute, Observational and Pragmatic Research Institute, Singapore

Professor Price

Editor-In-Chief: Professor David Price, FRCGP, UK
 
David Price completed his medical degree at Cambridge University in 1984 and his general practitioner training in Norwich in 1989. Between 1990 and 2000, he worked as a principal in general practice in Norwich, and he continues to work there as a GP with a special interest in respiratory disease. David Price is currently the Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen, Scotland. He is the founder and managing director of Research in Real Life in UK, and founder and director of Optimum Patient Care in UK and Observational & Pragmatic Research Institute in Singapore.

David Price is extensively involved in respiratory and allergy education and research. His areas of interest are ‘real-life’ effectiveness and cost-effectiveness of interventions, clinical trial design, compliance, and patient attitudes to their disease. He has authored over 300 peer-reviewed publications since 2000 and is responsible for approximately US$20 million in research and clinical development grants. David Price founded the Respiratory Effectiveness Group (www.effectivenessevaluation.org), a not-for-profit, investigator-led initiative, which uses an international collaborative approach to explore the role of real-life research in informing clinical guidelines and improving patient care.


Editorial Board

Rohit R Arora, MD, FACC, FAHA, FACP, FSCAI, Professor of Medicine, Professor of Physiology and biophysics, Chairman of Cardiology, Associate Chairman of Medicine for Research, The Chicago Medical School, Illinois, USA.

Huili Gan, Professor of Cardiac Surgery, Anzhen Hospital, Affiliated to Capital University of Medical Sciences, Beijing, People's Republic of China

Stefan Glück, VP Global Medical Affairs, Professor of Medicine, Celgene Corporation, USA.

Mario Gonzalez de la Parra, Professor, School of Chemistry of the Universidad Nacional Autonoma de Mexico, Scientific Director, Naucalpan, Mexico.

John Haughney, Associate Director, Clinical R&D, NHS Greater Glasgow and Clyde, Glasgow UK; Senior Research fellow, University of Aberdeen, Aberdeen UK

Sabzali Javadov, Professor, Department of Physiology, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA.

Amanda Lee, Professor of Medical Statistics and Head of the College of Life Sciences' Medical Statistics Team, University of Aberdeen, Aberdeen, Scotland, UK

Kyu Lim, Professor, Department of Biochemistry, College of Medicine, Cancer Research Institute, Infection Signaling Network Research Center, Chungnam National University, Korea.

Christoph R. Meier, Professor, Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland

Arshag D. Mooradian, Professor of Medicine, Chairman, Department of Medicine, University of Florida, Jacksonville, Florida, USA.

Aron D. Mosnaim, Professor, Department of Cellular and Molecular Pharmacology, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, North Chicago, Illinois, USA.

Emilio Perucca, Professor of Pharmacology, University of Pavia, Director of the Clinical Trial Centre at the Institute of Neurology IRCCS C. Mondino Foundation, Pavia, Italy.

Mike Thomas, Professor of Primary Care Research, University of Southampton, UK; Aldermoor Health Centre, Aldermoor Close, Southampton, UK

Thomas Chang Yao Tsao, Professor of Medicine, Chung Shan Medical University, Taichung, Taiwan.

T. van der Molen, Professor, Department of General Practice, University of Groningen, The Netherlands